サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1741408

ペインパッチ市場：タイプ別、用途別、技術別、剤形別、処方別、患者年齢別、粘着特性別、作用時間別、薬剤クラス別、流通チャネル別、地域別

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography

出版日
ページ情報
英文 160 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
ペインパッチ市場：タイプ別、用途別、技術別、剤形別、処方別、患者年齢別、粘着特性別、作用時間別、薬剤クラス別、流通チャネル別、地域別
出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ペインパッチ市場は、2025年には58億3,000万米ドルと推定され、2032年には82億米ドルに達する見込みで、2025年から2032年までのCAGRで5％の成長が予測されています。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 58億3,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間：2025年～2032年 CAGR： 5.00% 2032年の価値予測 82億米ドル

ペインパッチは、経皮パッチとしても知られ、局所的な痛みを緩和するために皮膚から直接薬物を送達する粘着パッチです。これらのパッチは便利で使いやすく、長期間にわたって薬物の放出を制御できます。

市場力学：

ペインパッチ市場は、主に関節炎、腰痛、神経障害性疼痛などの慢性疼痛症状の有病率の増加によって牽引されています。これらの疾患には長期的な疼痛管理ソリューションが必要であり、ペインパッチは便利で効果的な選択肢を提供します。さらに、中毒や胃腸の副作用など、経口鎮痛剤に関連する潜在的なリスクに対する意識の高まりにより、ペインパッチのような非侵襲的ドラッグデリバリーシステムへの注目が高まっています。

しかし、市場成長の妨げとなる要因もあります。従来の鎮痛薬に比べてペインパッチのコストが高いこと、一部の地域ではこれらの製品に対する償還が限られていることが、市場の拡大を制限する可能性があります。さらに、ペインパッチの承認には厳しい規制要件があり、パッチの使用に伴う皮膚刺激やアレルギー反応のリスクが市場成長の課題となっています。

こうした課題にもかかわらず、ペインパッチ市場にはいくつかの成長機会があります。ペインパッチにおけるワイヤレス接続やセンサー統合などの先端技術の採用が増加しているため、技術革新と製品差別化の道が開けています。さらに、新興市場の未開拓の可能性と個別化された疼痛管理ソリューションに対する需要の高まりは、市場プレーヤーがプレゼンスを拡大し、多様な消費者層に対応する機会を提供します。

本調査の主な特徴

  • 本レポートでは、世界のペインパッチ市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のペインパッチ市場の主要企業をプロファイルしています。
  • このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 世界のペインパッチ市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界のペインパッチ市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 効果的な痛みの緩和と非侵襲的な治療に対する需要の高まり
    • 皮膚の敏感性と炎症
    • 個別化された疼痛管理の出現
  • 影響分析
  • 主なハイライト
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ

第4章 ペインパッチ市場 - コロナウイルス（COVID-19）パンデミックの影響

  • COVID-19疫学
  • 供給側と需要側の分析
  • 経済への影響

第5章 ペインパッチ市場、タイプ別、2020年～2032年

  • オピオイド
  • 非オピオイド

第6章 ペインパッチ市場、用途別、2020年～2032年

  • 慢性疼痛
  • 急性疼痛

第7章 ペインパッチ市場、技術別、2020年～2032年

  • 従来型ドラッグデリバリーパッチ
  • 先進ドラッグデリバリーパッチ

第8章 ペインパッチ市場、剤形別、2020年～2032年

  • 単剤
  • 併用療法

第9章 ペインパッチ市場、処方別、2020年～2032年

  • 処方
  • OTC

第10章 ペインパッチ市場、患者年齢別、2020年～2032年

  • 成人
  • 小児

第11章 ペインパッチ市場、粘着特性別、2020年～2032年

  • 低アレルギー性
  • 標準

第12章 ペインパッチ市場、作用時間別、2020年～2032年

  • 短時間作用性
  • 徐放性

第13章 ペインパッチ市場、薬剤クラス別、2020年～2032年

  • NSAIDパッチ
  • 局所麻酔パッチ
  • その他

第14章 ペインパッチ市場、流通チャネル別、2020年～2032年

  • 小売薬局
  • 病院・クリニック

第15章 ペインパッチ市場、地域別、2020年～2032年

  • 北米
      • 米国
      • カナダ
  • 欧州
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋地域
  • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
      • その他ラテンアメリカ
  • 中東
      • GCC
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 中央アフリカ
      • 北アフリカ

第16章 競合情勢

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

第17章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI6204

Pain Patch Market is estimated to be valued at USD 5.83 Bn in 2025 and is expected to reach USD 8.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.83 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.00% 2032 Value Projection: USD 8.2 Bn

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • Global Pain Patch Market, By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • Global Pain Patch Market, By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • Global Pain Patch Market, By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • Global Pain Patch Market, By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • Global Pain Patch Market, By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • Global Pain Patch Market, By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • Global Pain Patch Market, By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • Global Pain Patch Market, By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • Global Pain Patch Market, By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • Global Pain Patch Market, By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • Global Pain Patch Market, By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Pain Patch Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Pain Patch Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Pain Patch Market, By Formulation, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Pain Patch Market, By Prescription, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

15. Pain Patch Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • South Africa
      • Central Africa
      • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endo Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teikoku Pharma USA, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Acorda Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ibsa Institut Biochimique SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Noven Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Strativa Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Galen Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Napp Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

17. Section

  • Research Methodology
  • About us